Barbara Ziffels
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An antibody-based enzymatic therapy for cancer treatment: The selective localization of D-amino acid oxidase to EDA fibronectin.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: November 22, 2020
A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell Carcinomas.
Journal: Frontiers in oncology
Published: August 23, 2019
Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation.
Journal: Journal of biotechnology
Published: December 04, 2018
Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice.
Journal: Molecular cancer therapeutics
Published: November 21, 2018
Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2017
Antibody-Based Targeted Delivery of Interleukin-22 Promotes Rapid Clinical Recovery in Mice With DSS-Induced Colitis.
Journal: Inflammatory bowel diseases
Published: August 03, 2016
Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.
Journal: Protein engineering, design & selection : PEDS
Published: July 14, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026